Connect with us
German drug-maker Bayer AG is negotiating to buy out partner, Algeta SA.

archive

Bayer to Acquire Partner, Algeta

German drug-maker Bayer AG is negotiating to buy out partner, Algeta SA.

Bayer to Acquire Partner, Algeta (Bloomberg)

German drug-maker Bayer AG is negotiating to buy out partner, Algeta SA. The Norway-based drug company currently shares control of its prostate cancer medicine with Germanyâ??s Bayer. Under the proposed deal, Bayer would take full control of the drug, along with a pipeline of experimental radiation therapies. Bayer has offered 14.8 billion kroner (about $2.42 billion) for Algeta, a price which would value Algeta at a 27 percent premium to yesterdayâ??s close. Looking ahead, itâ??s unclear what effect the acquisition will have on Bayerâ??s bottom line.

Newsletter Signup.

Sign up to the Human Events newsletter

Written By

Advertisement
Advertisement

TRENDING NOW:

Everyone’s Gone Nuts. For Power and Profit.

CULTURE

Piers Morgan and Ilhan Omar Piers Morgan and Ilhan Omar

What’s The Difference Between Ilhan Omar and Piers Morgan?

U.S. POLITICS

CNN Platforms white nationalist Richard Spencer CNN Platforms white nationalist Richard Spencer

CNN Platforms Richard Spencer.

U.S. POLITICS

Planned Parenthood’s Leana Wen Wasn’t Woke Enough And Nor Are You

CULTURE

Connect
Newsletter Signup.

Sign up to the Human Events newsletter